TECHWIRE 30
(CIX: WRAL30)  1,160.54  down arrow-3.1  (-0.27 %)  Updated: 08:10 PM EDT, Apr 01 2015
(NQ: Apple)  124.25  down arrow-0.18  (-0.14 %)  Updated: 08:10 PM EDT, Apr 01 2015
(NY: QUINTILES)  67.87  up arrow+0.9  (1.34 %)  Updated: 06:40 PM EDT, Apr 01 2015
(OP: BASF SE)  100.70  up arrow+1.24  (1.24 %)  Updated: 05:20 PM EDT, Apr 01 2015
(NQ: BioCryst)  9.99  up arrow+0.96  (10.63 %)  Updated: 08:10 PM EDT, Apr 01 2015
(NQ: BioDelivery)  10.11  down arrow-0.39  (-3.71 %)  Updated: 08:10 PM EDT, Apr 01 2015
(NQ: CEMP)  34.88  up arrow+0.57  (1.66 %)  Updated: 08:10 PM EDT, Apr 01 2015
(NQ: Cisco Systems)  27.25  down arrow-0.28  (-1 %)  Updated: 08:10 PM EDT, Apr 01 2015
(NQ: Cree)  35.17  down arrow-0.32  (-0.9 %)  Updated: 08:10 PM EDT, Apr 01 2015
(NQ: DARA)  0.74  up arrow+0.01  (1.23 %)  Updated: 08:10 PM EDT, Apr 01 2015
(NY: EMC CORPORATION)  25.47  down arrow-0.09  (-0.35 %)  Updated: 06:40 PM EDT, Apr 01 2015
(NQ: Extreme Networks)  3.25  up arrow+0.09  (2.85 %)  Updated: 08:10 PM EDT, Apr 01 2015
(NQ: FB)  81.67  down arrow-0.55  (-0.67 %)  Updated: 08:10 PM EDT, Apr 01 2015
(NY: GLAXOSMITHKLINE)  46.69  up arrow+0.54  (1.17 %)  Updated: 06:40 PM EDT, Apr 01 2015
(NQ: GOOG)  542.56  down arrow-5.44  (-0.99 %)  Updated: 08:10 PM EDT, Apr 01 2015
(NY: IBM)  159.18  down arrow-1.32  (-0.82 %)  Updated: 06:40 PM EDT, Apr 01 2015
(NY: LH)  125.88  down arrow-0.21  (-0.17 %)  Updated: 06:40 PM EDT, Apr 01 2015
(OP: Lenovo Group)  29.05  down arrow-0.1  (-0.34 %)  Updated: 05:20 PM EDT, Apr 01 2015
(NY: MRK)  56.86  down arrow-0.62  (-1.08 %)  Updated: 06:40 PM EDT, Apr 01 2015
(NQ: Microsoft Corp)  40.72  up arrow+0.07  (0.16 %)  Updated: 08:10 PM EDT, Apr 01 2015
(NQ: NTAP)  35.27  down arrow-0.19  (-0.54 %)  Updated: 08:10 PM EDT, Apr 01 2015
(NY: NOVARTIS AG)  99.86  up arrow+1.25  (1.27 %)  Updated: 06:40 PM EDT, Apr 01 2015
(OP: Novozymes A/S)  46.59  up arrow+0.91  (1.99 %)  Updated: 05:20 PM EDT, Apr 01 2015
(NY: PFIZER)  34.33  down arrow-0.46  (-1.32 %)  Updated: 06:40 PM EDT, Apr 01 2015
(NQ: Pozen)  7.69  down arrow-0.03  (-0.39 %)  Updated: 08:10 PM EDT, Apr 01 2015
(NY: RED HAT)  75.39  down arrow-0.36  (-0.48 %)  Updated: 06:40 PM EDT, Apr 01 2015
(NQ: BBRY)  8.90  down arrow-0.03  (-0.34 %)  Updated: 08:10 PM EDT, Apr 01 2015
(NQ: Salix)  172.81    (0 %)  Updated: 08:10 PM EDT, Apr 01 2015
(NQ: SQI)  16.25  down arrow-0.68  (-4.02 %)  Updated: 08:10 PM EDT, Apr 01 2015

Posts tagged “Genomics”

9:02 a.m. Tuesday

Premium Lock So why did Quintiles form a joint venture to take on LabCorp?

DNA      Quintiles, the world's largest life science services company, is going to get even bigger - but through a joint venture rather than an acquisition. The deal announced Tuesday to partner with Quest to take on No. 1 lab tester LabCorp is seen as the best way for Quintiles to capitalize on a changing market, a Q executive explains.

March 12

Decoding your genome could extend your life

Human Longevity Inc. Some of the technologies and methods researchers say will allow humans to live far beyond today's life expectancies might seem a bit sci-fi, but last week's CED Life Science Conference presentation by a California scientist behind national headline-grabbing Human Longevity Inc. considers the equally radical inventions of the last 150 years.

March 4

Red Hat's 'cloud' practice; AT&T, Cisco link cars; Uber's buy; AT&T's mobile health move; Sony VR headsets coming

Bulldog In today's Bulldog wrapup of technology and life science news: Red Hat launches a "cloud" practice offering services and technology; AT&T and Cisco team up to connect vehicles; Uber buys a mapping firm; AT&T moves into mobile connected health; and Sony to launch virtual reality headsets next year.

March 3

Ikea 'smart' furniture; Aerie's loss; EU modified crop crackdown; $11.8B chip deal; new jet tracking tech

Bulldog In today's Bulldog wrapup of technology and life science news: Ikea launches "smart" furniture; Aerie Pharmaceuticals reports a loss; EU gives members power to crack down on genetically modified crops; Freescale Semiconductor is sold for $11.8 billion; and new technology will track jetliners.

February 20

Premium Lock DNA breakthrough: FDA approves 23andMe, other tests

DNA      Federal health officials are easing access to DNA tests used to screen parents for devastating genetic disorders that can be passed on to their children. The surprise announcement Thursday offers a path forward for Google-backed genetic testing firm 23andMe, which previously clashed with regulators over its direct-to-consumer technology.

November 21, 2014

Premium Lock Summit showcase: NCSU reaping big harvest in agbio research

Agbio Agriculture research at N.C. State highlights the AgBio Summit with developments spanning robots and drones to honey bees and fish. WRAL TechWire's Allan Maurer reports exclusively for our Insiders.

Updated November 19, 2014

Premium Lock Population bomb: 'The mother of all wicked problems'

Feeding a world population the United Nations estimates will hit 9 billion by 2050 is only one of the social problems caused by an increasing number of people, the director of of the US Department of Agriculture's National Institute of Food and Agriculture tells the AgBio Summit in Raleigh. WRAL TechWire's Allan Maurer reports the details for our Insiders.

Talking population problems at AgBio Summit Talking population problems at AgBio Summit

Updated November 18, 2014

Premium Lock Syngenta faces dozens of lawsuits over genetically modified seed

Agrochemicals giant Syngenta is facing a growing number of lawsuits challenging its release of a genetically modified corn seed that China had not approved for import, with losses to farmers estimated to be at least $1 billion.

Growing corn at Syngenta's new lab Growing corn at Syngenta's new lab

November 18, 2014

Premium Lock Just call North Carolina 'the Mecca, the hub for agbio'

Agbio As NC State prepares to host the AGBIO Summit, the dean of the university's College of Agriculture and Life Sciences says the event will help showcase North Carolina as the "Mecca, the hub for agio." The theme of the event: Feeding a world of 9 billion people in 2050. And action is required, reports WRAL TechWire's Allan Maurer.

Updated August 15, 2014

Premium Lock Ebola outbreak brings global attention to tobacco plant-based drugs

It's an eye-catching angle in the story of an experimental treatment for Ebola: The drug comes from tobacco plants that were turned into living pharmaceutical factories. And one of the emerging players is Medicago, which operates a production facility in RTP.

How Medicago process works How Medicago process works

August 12, 2014

Premium Lock Pfizer, 23andMe team up for genetic study of bowel disease

DNA      Pfizer is teaming up with DNA testing company 23andMe to study the possible genetic underpinnings of inflammatory bowel disease, a hard-to-treat ailment that affects an estimated 1.4 million Americans.

Updated July 14, 2014

Premium Lock N.C. Research Campus internship program plants seeds to grow STEM careers

The future of food research is taking root in some very fertile ground - the minds of students working on the N.C. Research Campus. In an Insider exclusive for WRAL TechWire, read how a new internship program encourages STEM careers

Michael Balloskis, left, and Brooklyn Phillips in the P2EP program. Michael Balloskis, left, and Brooklyn Phillips in the P2EP program.

Updated June 24, 2014

Premium Lock New Jersey firm buying Gentris for $4.75M; founder to return

Morrisville-based Gentris, which provides storage and testing services to research laboratories, has received a $4.75 million buy-out offer from New Jersey-based Cancer Genetics,

Gentris Gentris

May 13, 2014

Premium Lock GSK to utilize genomics data, services from Metabolon

Triangle-based Metabolon, which recently struck a deal with DNA pioneer Craig Venter to help us find ways to live longer, has another high-profile partner: GlaxoSmithKline. The two neighbors disclosed a new collaboration agreement Tuesday.

Metabolon’s “Analytical Platform”: Metabolon’s “Analytical Platform”:

April 2, 2014

Premium Lock Drug giant Baxter acquires Chapel Hill firm for $70M

Heart research Baxter International is acquiring Chapel Hill-based Chatham Therapeutics to gain control of gene-based therapy technology focused on hemophilia. The deal includes a $70 million upfront payment. Additional payments could be made based on development, regulatory and commercial milestones.

Updated March 29, 2014

Premium Lock On Human Genome Project anniversary, NHGRI's Green sees Big Data bottlenecks ahead

Eric Green National Human Genome Research Institute Director Eric Green recognizes the progress made since the first human genome was sequenced 10 years ago. Read about the Big Data challenges he sees ahead.

Updated March 28, 2014

Premium Lock Vivek Wadhwa: A story about the $32,000 startup sold for millions

Vivek Wadhwa I meet entrepreneurs all over the world who think that venture capital is a prerequisite for starting a company. They write business plans and ask for introductions to venture capitalists. I tell them that they should instead bootstrap their startups; that what would have cost millions of dollars a few years ago now costs thousands. This story is about one startup that bootstrapped, rebooted and sold for millions.

Updated March 19, 2014

Premium Lock Vivek Wadhwa: Humans have become software; amazing advances lie ahead

Vivek Wadhwa Opinion: Hardly a week goes by without the announcement of a major scientific breakthrough in genomics. This means that medicine will, within a few years, start advancing at the same pace as the Internet and software. And, we will see a revolution in health care.

Updated March 6, 2014

Premium Lock Genome pioneer Craig Venter launches DNA firm aiming to help us all live to be 100

J. Craig Venter, the man who raced the U.S. government to sequence the first human genome, has a new goal: Help everyone live to 100, in good health. And one of his first partners is RTP-based Metabolon, where he serves as a scientific adviser.

A sample of testing done at Craig Venter's new firm A sample of testing done at Craig Venter's new firm

Updated March 6, 2014

Premium Lock RTP's Metabolon to help genome pioneer Craig Venter find ways to help us live longer

Metabolon will utilize its proprietary molecular technology to help Human Longevity Inc., the new company led by genome pioneer Craig Venter, to find indications of disease and gene mutations.

Mapping the genome Mapping the genome

Techwire Inside Partners
The Skinny: A Blog by Rick Smith